33. Primary Human Tissue Models for Metabolic Dysfunction-Associated Liver Disease - toward Streamlining Drug Discovery with Patient-Derived Assays

Previous
Previous

34. What is in a name? Rethinking SMUG1 in genome maintenance

Next
Next

32. Nucleobase catalysts for the enzymatic activation of 8-oxoguanine DNA glycosylase 1